DENNIS MULROY - 03 Jan 2025 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
03 Jan 2025
Net transactions value
-$81,168
Form type
4
Filing time
07 Jan 2025, 17:32:42 UTC
Previous filing
17 Sep 2024
Next filing
18 Dec 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Options Exercise +8,293 +145% 14,018 03 Jan 2025 Direct F1, F2
transaction ANAB Common Stock Tax liability $49,742 -3,407 -24% $14.60 10,611 03 Jan 2025 Direct F3, F4
transaction ANAB Common Stock Options Exercise +5,245 +49% 15,856 06 Jan 2025 Direct F1
transaction ANAB Common Stock Tax liability $31,426 -2,054 -13% $15.30 13,802 06 Jan 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Restricted Stock Unit Options Exercise $0 -8,293 -25% $0.000000 24,877 03 Jan 2025 Common Stock 8,293 Direct F1, F5
transaction ANAB Restricted Stock Unit Options Exercise $0 -5,245 -33% $0.000000 10,490 06 Jan 2025 Common Stock 5,245 Direct F1, F6
transaction ANAB Restricted Stock Unit Award $0 +26,800 $0.000000 26,800 07 Jan 2025 Common Stock 26,800 Direct F1, F7
transaction ANAB Stock Option (right to buy) Award $0 +76,400 $0.000000 76,400 07 Jan 2025 Common Stock 76,400 $14.83 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 Reflects the acquisition of 981 shares acquired under the Company's ESPP.
F3 Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.
F4 The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
F5 The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F6 The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F7 The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F8 The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.